{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:03:43Z","timestamp":1792785823586,"version":"4.5.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"am","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.03-2024-03"],"award-info":[{"award-number":["WE.03-2024-03"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.15-2022-04"],"award-info":[{"award-number":["WE.15-2022-04"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020140","name":"Amsterdam Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020140","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Stichting Alzheimer Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stichting Steun Alzheimercentrum Amsterdam"},{"name":"Pasman stichting"},{"DOI":"10.13039\/501100010573","name":"Stichting Dioraphte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016997","name":"Noaber Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014041","name":"Alzheimer's Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019211","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007742","name":"BioClinica, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CereSpir, Inc."},{"name":"Cogstate"},{"DOI":"10.13039\/501100023368","name":"Eisai Incorporated","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023368","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elan Pharma","id":[{"id":"https:\/\/ror.org\/02s1xv184","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EuroImmun"},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005062","name":"Fujirebio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Europe"},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015725","name":"IXICO Ltd.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015324","name":"Janssen Alzheimer Immunotherapy Research And Development, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014489","name":"Johnson and Johnson Pharmaceutical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014489","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lumosity"},{"DOI":"10.13039\/501100013327","name":"Lundbeck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NeuroRx Research","id":[{"id":"https:\/\/ror.org\/02r8axs93","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Neurotrack Technologies","id":[{"id":"https:\/\/ror.org\/05f8ada11","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Piramal Imaging"},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Transition Therapeutics"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ADG-101096455"],"award-info":[{"award-number":["ADG-101096455"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","award":["ZEN24-1069572"],"award-info":[{"award-number":["ZEN24-1069572"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer\u2019s Association","doi-asserted-by":"publisher","award":["SG-23-1061717"],"award-info":[{"award-number":["SG-23-1061717"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015595","name":"GHR Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-00775"],"award-info":[{"award-number":["2022-00775"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2018-02052"],"award-info":[{"award-number":["2018-02052"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2021-02219"],"award-info":[{"award-number":["2021-02219"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERA PerMed","award":["ERAPERMED2021-184"],"award-info":[{"award-number":["ERAPERMED2021-184"]}]},{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg foundation","doi-asserted-by":"publisher","award":["2022-0231"],"award-info":[{"award-number":["2022-0231"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-980907"],"award-info":[{"award-number":["AF-980907"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-994229"],"award-info":[{"award-number":["AF-994229"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008599","name":"Alzheimerfonden","doi-asserted-by":"publisher","award":["AF-1011949"],"award-info":[{"award-number":["AF-1011949"]}],"id":[{"id":"10.13039\/501100008599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007416","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2021-0293"],"award-info":[{"award-number":["FO2021-0293"]}],"id":[{"id":"10.13039\/501100007416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007416","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2023-0163"],"award-info":[{"award-number":["FO2023-0163"]}],"id":[{"id":"10.13039\/501100007416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007416","name":"Hj\u00e4rnfonden","doi-asserted-by":"publisher","award":["FO2024-0284"],"award-info":[{"award-number":["FO2024-0284"]}],"id":[{"id":"10.13039\/501100007416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinsonfonden","doi-asserted-by":"publisher","award":["1412\/22"],"award-info":[{"award-number":["1412\/22"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021728","name":"Bundy Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer\u2019s fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The R\u00f6nstr\u00f6m Family Foundation","award":["FRS-0011"],"award-info":[{"award-number":["FRS-0011"]}]},{"name":"The R\u00f6nstr\u00f6m Family Foundation","award":["FRS-0004"],"award-info":[{"award-number":["FRS-0004"]}]},{"name":"Berg Family Foundation"},{"DOI":"10.13039\/100000864","name":"Michal J. Fox Foundation","doi-asserted-by":"publisher","award":["MJFF-025507"],"award-info":[{"award-number":["MJFF-025507"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michal J. Fox Foundation","doi-asserted-by":"publisher","award":["WASP\/DDLS22-066"],"award-info":[{"award-number":["WASP\/DDLS22-066"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006129","name":"Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5ne University Hospital Foundation","doi-asserted-by":"publisher","award":["2020-O000028"],"award-info":[{"award-number":["2020-O000028"]}],"id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regionalt Forskningsst\u00f6d","award":["2022-1259"],"award-info":[{"award-number":["2022-1259"]}]},{"DOI":"10.13039\/501100009750","name":"Kamprad Family Foundation","doi-asserted-by":"publisher","award":["20243058"],"award-info":[{"award-number":["20243058"]}],"id":[{"id":"10.13039\/501100009750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007190","name":"Sveriges Regering","doi-asserted-by":"publisher","award":["2022-Projekt0080"],"award-info":[{"award-number":["2022-Projekt0080"]}],"id":[{"id":"10.13039\/501100007190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007190","name":"Sveriges Regering","doi-asserted-by":"publisher","award":["2022-Projekt0107"],"award-info":[{"award-number":["2022-Projekt0107"]}],"id":[{"id":"10.13039\/501100007190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U24 NS072026"],"award-info":[{"award-number":["U24 NS072026"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG019610"],"award-info":[{"award-number":["P30 AG019610"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG072980"],"award-info":[{"award-number":["P30AG072980"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG083740"],"award-info":[{"award-number":["R01AG083740"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007306","name":"Arizona Department of Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008335","name":"Arizona Biomedical Research Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"NWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health\u223cHolland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ERA PerMed"},{"DOI":"10.13039\/501100003792","name":"Hjarnfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Among amyloid-positive individuals with symptomatic Alzheimer\u2019s disease, older age and male sex have been associated with a lower prevalence of Tau-PET-positivity. Whether Tau-PET-negative older and\/or male individuals truly do not harbour widespread tau pathology or whether tangle density is below the PET detection threshold remains unknown. Therefore, we aimed to investigate the neuropathological correlates of age and sex differences in Tau-PET in independent PET-only, autopsy-only and PET-to-autopsy cohorts.<\/jats:p>\n                  <jats:p>In the PET-only cohort, we included amyloid-\u03b2-positive participants with mild cognitive impairment (MCI) or dementia who underwent 18F-flortaucipir PET (n = 672). In the autopsy-only cohort, we included participants with moderate-to-frequent Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD) scores and MCI or dementia with available data on Braak stage and tangle density (n = 945). In the PET-to-autopsy cohort, we included participants who underwent ante-mortem Tau-PET and had undergone a post-mortem assessment of Braak staging (n = 85; median PET-to-post-mortem interval: 2.6 months). A subset additionally had tangle density data available (n = 63). Tau-PET standardized uptake value ratio (SUVr) was calculated in a temporal meta-region, and Tau-PET-positivity was defined using a predefined threshold of 1.36 SUVr. Autopsy cases were categorized as Braak 0\u2013IV versus Braak V\u2013VI.<\/jats:p>\n                  <jats:p>In PET-only analyses (age: 71.9 \u00b1 8.2, 52.8% male), older age and male sex were associated with a lower prevalence of Tau-PET-positivity and lower Tau-PET SUVr (all P &amp;lt; 0.05). In autopsy-only analyses (age: 82.7 \u00b1 7.9, 54.6% male), older age and male sex were associated with a lower prevalence of Braak V\u2013VI neuropathology (both P &amp;lt; 0.05). Among Braak V\u2013VI autopsy cases (n = 598), older age was associated with lower tangle density (\u03b2 = \u22120.38, P &amp;lt; 0.001). In PET-to-autopsy analyses (age: 81.7 \u00b1 9.2, 52.9% male), Tau-PET showed excellent specificity for detecting Braak V\u2013VI neuropathology (100% across age-stratified and sex-stratified models), while the sensitivity decreased at older age [&amp;lt;83 years: 92% (95% confidence interval: 80%\u2013100%) versus \u226583 years: 42% (23%\u201362%)] and in males [females: 85% (69%\u201396%) versus males: 48% (28%\u201368%)]. Older and male participants with Braak V\u2013VI neuropathology showed both lower Tau-PET SUVr (age: \u03b2 = \u22120.46, P = 0.003; sex: \u03b2 = \u22120.97, P = 0.001), and in the same individuals, older participants showed trend-level lower tangle density (\u03b2 = \u22120.31, P = 0.053). The lack of age\/sex interactions suggests that the relationship between Tau-PET and tangle density is consistent across ages and sexes.<\/jats:p>\n                  <jats:p>Comprehensive and independent PET, autopsy and PET-to-autopsy analyses demonstrate that the associations of older age and male sex with lower 18F-flortaucipir PET uptake and positivity rates can be explained by lower tangle densities. 18F-flortaucipir PET SUVr thus closely reflects tangle density, which accounts for the lower sensitivity of 18F-flortaucipir PET for detecting low-density Braak V\u2013VI tau pathology in older individuals and males.<\/jats:p>","DOI":"10.1093\/brain\/awag136","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:41:01Z","timestamp":1776339661000},"source":"Crossref","is-referenced-by-count":3,"title":["Neuropathological correlates of age and sex differences in 18F-flortaucipir PET"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-9101","authenticated-orcid":false,"given":"Emma M","family":"Coomans","sequence":"first","affiliation":[{"name":"Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC , Amsterdam 1081 HZ ,","place":["The Netherlands"]},{"name":"Amsterdam Neuroscience, Neurodegeneration \u00a0 Amsterdam 1081 BT ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7147-0112","authenticated-orcid":false,"given":"Ruben","family":"Smith","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]},{"name":"Memory Clinic, Sk\u00e5ne University Hospital , Malm\u00f6 205 02 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]},{"name":"Department of Neurology, Sk\u00e5ne University Hospital , Lund 222 42 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Oliveira Hauer","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1930","authenticated-orcid":false,"given":"Sebastian","family":"Palmqvist","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]},{"name":"Memory Clinic, Sk\u00e5ne University Hospital , Malm\u00f6 205 02 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Stomrud","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]},{"name":"Memory Clinic, Sk\u00e5ne University Hospital , Malm\u00f6 205 02 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8885-7724","authenticated-orcid":false,"given":"Niklas","family":"Mattsson-Carlgren","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]},{"name":"Memory Clinic, Sk\u00e5ne University Hospital , Malm\u00f6 205 02 ,","place":["Sweden"]},{"name":"Wallenberg Center for Molecular Medicine, Lund University , Lund 223 62 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-7421","authenticated-orcid":false,"given":"Cecilia","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Banner Sun Health Research Institute , Sun City, AZ 85351 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9527-2011","authenticated-orcid":false,"given":"Geidy E","family":"Serrano","sequence":"additional","affiliation":[{"name":"Banner Sun Health Research Institute , Sun City, AZ 85351 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G","family":"Beach","sequence":"additional","affiliation":[{"name":"Banner Sun Health Research Institute , Sun City, AZ 85351 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke J","family":"Rozemuller","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vrije Universiteit Amsterdam, Amsterdam UMC , Amsterdam 1081 HZ ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande","family":"Pijnenburg","sequence":"additional","affiliation":[{"name":"Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC , Amsterdam 1081 HZ ,","place":["The Netherlands"]},{"name":"Amsterdam Neuroscience, Neurodegeneration \u00a0 Amsterdam 1081 BT ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsmarieke","family":"van de Giessen","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Vrije Universiteit Amsterdam, Amsterdam UMC , Amsterdam 1081 HZ ,","place":["The Netherlands"]},{"name":"Amsterdam Neuroscience, Brain Imaging \u00a0 Amsterdam 1081 BT ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Kotari","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis 46285 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pontecorvo","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis 46285 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Shcherbinin","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company , Indianapolis 46285 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-7286","authenticated-orcid":false,"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[{"name":"Department of Neurology, Alzheimer Center Amsterdam, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC , Amsterdam 1081 HZ ,","place":["The Netherlands"]},{"name":"Amsterdam Neuroscience, Neurodegeneration \u00a0 Amsterdam 1081 BT ,","place":["The Netherlands"]},{"name":"Clinical Memory Research Unit, Department of Clinical Sciences in Malm\u00f6, Lund University , Lund 222 42 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"Suppl 1","key":"2026091620314703100_awag136-B1","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.121.263196","article-title":"Tau PET imaging in neurodegenerative disorders","volume":"63","author":"Groot","year":"2022","journal-title":"J Nucl Med"},{"key":"2026091620314703100_awag136-B2","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awz090","article-title":"A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer\u2019s disease dementia","volume":"142","author":"Pontecorvo","year":"2019","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B3","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/brain\/awaa248","article-title":"Predicting future rates of tau accumulation on PET","volume":"143","author":"Jack","year":"2020","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B4","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1093\/brain\/awaa327","article-title":"The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects","volume":"143","author":"Smith","year":"2020","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.04.003","article-title":"Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer\u2019s continuum: Greater tau-PET retention in females","volume":"105","author":"Edwards","year":"2021","journal-title":"Neurobiol Aging"},{"key":"2026091620314703100_awag136-B6","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41593-025-02000-6","article-title":"Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-beta status, APOE genotype and sex","volume":"28","author":"Ossenkoppele","year":"2025","journal-title":"Nat Neurosci"},{"key":"2026091620314703100_awag136-B7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jama.2025.7817","article-title":"Frequency and clinical outcomes associated with tau positron emission tomography positivity","volume":"334","author":"Moscoso","year":"2025","journal-title":"JAMA"},{"key":"2026091620314703100_awag136-B8","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00259-020-05099-w","article-title":"The impact of demographic, clinical, genetic, and imaging variables on tau PET status","volume":"48","author":"Ossenkoppele","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026091620314703100_awag136-B9","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/alz.13609","article-title":"Individuals with Alzheimer\u2019s disease and low tau burden: Characteristics and implications","volume":"20","author":"Landau","year":"2024","journal-title":"Alzheimers Dement"},{"key":"2026091620314703100_awag136-B10","doi-asserted-by":"crossref","first-page":"e1850","DOI":"10.1212\/WNL.0000000000207794","article-title":"Performance of a [(18)F]flortaucipir PET visual read method across the Alzheimer disease continuum and in dementia with Lewy bodies","volume":"101","author":"Coomans","year":"2023","journal-title":"Neurology"},{"key":"2026091620314703100_awag136-B11","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14423","article-title":"Characterizing visual read tau-PET-negative participants with Alzheimer\u2019s disease dementia","volume":"21","author":"Rikken","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026091620314703100_awag136-B12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol"},{"key":"2026091620314703100_awag136-B13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"2026091620314703100_awag136-B14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ado8076","article-title":"Flortaucipir PET uncovers relationships between tau and amyloid-beta in primary age-related tauopathy and Alzheimer's disease","volume":"16","author":"Josephs","year":"2024","journal-title":"Sci Transl Med"},{"key":"2026091620314703100_awag136-B15","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-positron emission tomography correlates with neuropathology findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2026091620314703100_awag136-B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00401-024-02801-2","article-title":"Association of in vivo retention of [(18)f] flortaucipir pet with tau neuropathology in corresponding brain regions","volume":"148","author":"Freiburghaus","year":"2024","journal-title":"Acta Neuropathol"},{"key":"2026091620314703100_awag136-B18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13550-020-00653-x","article-title":"Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer\u2019s disease pathology: A clinicopathological study","volume":"10","author":"Pontecorvo","year":"2020","journal-title":"EJNMMI Res"},{"key":"2026091620314703100_awag136-B19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","article-title":"Correlation of in vivo [18F]flortaucipir with postmortem Alzheimer disease tau pathology","volume":"76","author":"Smith","year":"2019","journal-title":"JAMA Neurol"},{"key":"2026091620314703100_awag136-B20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00401-018-1908-x","article-title":"Sex and age interact to determine clinicopathologic differences in Alzheimer\u2019s disease","volume":"136","author":"Liesinger","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2026091620314703100_awag136-B21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/archneur.55.3.326","article-title":"Clinicopathologic studies in cognitively healthy aging and Alzheimer\u2019s disease: Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype","volume":"55","author":"Berg","year":"1998","journal-title":"Arch Neurol"},{"key":"2026091620314703100_awag136-B22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00401-018-1920-1","article-title":"Sex differences in Alzheimer\u2019s disease and common neuropathologies of aging","volume":"136","author":"Oveisgharan","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2026091620314703100_awag136-B23","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/brain\/awab099","article-title":"Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease","volume":"144","author":"Spina","year":"2021","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-201213","article-title":"Alzheimer\u2019s disease neuropathological comorbidities are common in the younger-old","volume":"79","author":"Beach","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"2026091620314703100_awag136-B25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/jnen\/nlw047","article-title":"Gender differences in Alzheimer disease: Brain atrophy, histopathology burden, and cognition","volume":"75","author":"Filon","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026091620314703100_awag136-B26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaneurol.2025.1100","article-title":"Evaluation of the revised criteria for biological and clinical staging of Alzheimer disease","volume":"82","author":"Pichet Binette","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026091620314703100_awag136-B28","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3233\/JAD-170850","article-title":"Amsterdam dementia cohort: Performing research to optimize care","volume":"62","author":"van der Flier","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2026091620314703100_awag136-B29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"2026091620314703100_awag136-B30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/neup.12189","article-title":"Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program","volume":"35","author":"Beach","year":"2015","journal-title":"Neuropathology"},{"key":"2026091620314703100_awag136-B31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13550-017-0284-1","article-title":"Partial volume correction of brain PET studies using iterative deconvolution in combination with HYPR denoising","volume":"7","author":"Golla","year":"2017","journal-title":"EJNMMI Res"},{"key":"2026091620314703100_awag136-B32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2018.12917","article-title":"Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders","volume":"320","author":"Ossenkoppele","year":"2018","journal-title":"JAMA"},{"key":"2026091620314703100_awag136-B33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","article-title":"Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease","volume":"13","author":"Jack","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2026091620314703100_awag136-B34","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/acn3.51195","article-title":"Amyloid-beta PET and CSF in an autopsy-confirmed cohort","volume":"7","author":"Reimand","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2026091620314703100_awag136-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2026091620314703100_awag136-B36","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","article-title":"Unified staging system for Lewy body disorders: Correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction","volume":"117","author":"Beach","year":"2009","journal-title":"Acta Neuropathol"},{"key":"2026091620314703100_awag136-B37","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2967\/jnumed.124.268756","article-title":"Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup","volume":"66","author":"Rabinovici","year":"2025","journal-title":"J Nucl Med"},{"key":"2026091620314703100_awag136-B38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamaneurol.2019.5154","article-title":"Assessment of demographic, genetic, and imaging variables associated with brain resilience and cognitive resilience to pathological tau in patients with Alzheimer disease","volume":"77","author":"Ossenkoppele","year":"2020","journal-title":"JAMA Neurol"},{"key":"2026091620314703100_awag136-B39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2026091620314703100_awag136-B40","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","article-title":"Prevalence and clinical phenotype of quadruple misfolded proteins in older adults","volume":"77","author":"Karanth","year":"2020","journal-title":"JAMA Neurol"},{"key":"2026091620314703100_awag136-B41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026091620314703100_awag136-B42","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00259-020-05152-8","article-title":"Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts","volume":"48","author":"Provost","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026091620314703100_awag136-B43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med"},{"key":"2026091620314703100_awag136-B44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1474-4422(11)70156-9","article-title":"Neuropathologically defined subtypes of Alzheimer\u2019s disease with distinct clinical characteristics: A retrospective study","volume":"10","author":"Murray","year":"2011","journal-title":"Lancet Neurol"},{"key":"2026091620314703100_awag136-B45","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1038\/s41467-022-32592-7","article-title":"Earlier Alzheimer\u2019s disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading","volume":"13","author":"Frontzkowski","year":"2022","journal-title":"Nat Commun"},{"key":"2026091620314703100_awag136-B46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13024-025-00822-3","article-title":"Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer\u2019s disease","volume":"20","author":"Franzmeier","year":"2025","journal-title":"Mol Neurodegener"},{"key":"2026091620314703100_awag136-B47","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awaa438","article-title":"The development and convergence of co-pathologies in Alzheimer\u2019s disease","volume":"144","author":"Robinson","year":"2021","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B48","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awad397","article-title":"Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females","volume":"147","author":"Wang","year":"2024","journal-title":"Brain"},{"key":"2026091620314703100_awag136-B49","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2026091620314703100_awag136-B50","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamaneurol.2018.4693","article-title":"Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults","volume":"76","author":"Buckley","year":"2019","journal-title":"JAMA Neurol"},{"key":"2026091620314703100_awag136-B51","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jamaneurol.2025.0013","article-title":"Sex differences in longitudinal tau-PET in preclinical Alzheimer disease: A meta-analysis","volume":"82","author":"Coughlan","year":"2025","journal-title":"JAMA Neurol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awag136\/68117740\/awag136.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awag136\/68117740\/awag136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:32:07Z","timestamp":1789605127000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/advance-article\/doi\/10.1093\/brain\/awag136\/8659494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":51,"URL":"https:\/\/doi.org\/10.1093\/brain\/awag136","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"awag136"}}